Company

XyloCor Therapeutics

https://www.xylocor.com/

Industryclinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease

Funding raised

CompanyRoundDate
XyloCor TherapeuticsSeries B2025-01-08